Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence
Lasting immunity following SARS-CoV-2 infection is questioned because serum antibodies
decline in convalescence. However, functional immunity is mediated by long-lived memory T …
decline in convalescence. However, functional immunity is mediated by long-lived memory T …
A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry
HE Drummer, I Boo, AL Maerz… - Journal of virology, 2006 - Am Soc Microbiol
The hepatitis C virus (HCV) glycoproteins E1 and E2 form a heterodimer that mediates
CD81 receptor binding and viral entry. In this study, we used site-directed mutagenesis to …
CD81 receptor binding and viral entry. In this study, we used site-directed mutagenesis to …
Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1
HE Drummer, I Boo… - Journal of general …, 2007 - microbiologyresearch.org
The E1E2 glycoprotein heterodimer of Hepatitis C virus mediates viral entry. E2 attaches the
virus to cellular receptors; however, the function of E1 is unknown. We tested the hypothesis …
virus to cellular receptors; however, the function of E1 is unknown. We tested the hypothesis …
[PDF][PDF] The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs
PT Vietheer, I Boo, J Gu, K McCaffrey, S Edwards… - …, 2017 - Wiley Online Library
A vaccine that prevents hepatitis C virus (HCV) infection is urgently needed to support an
emerging global elimination program. However, vaccine development has been confounded …
emerging global elimination program. However, vaccine development has been confounded …
[HTML][HTML] A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
…, M Ciula, HE Drummer, S Redmond, HX Tan, I Boo… - …, 2021 - thelancet.com
Background As vaccines against SARS-CoV-2 are now being rolled out, a better understanding
of immunity to the virus, whether from infection, or passive or active immunisation, and …
of immunity to the virus, whether from infection, or passive or active immunisation, and …
[HTML][HTML] Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery
…, B Grubor-Bauk, DK Wijesundara, I Boo… - Scientific reports, 2019 - nature.com
The introduction of directly acting antiviral agents (DAAs) has produced significant improvements
in the ability to cure chronic hepatitis C infection. However, with over 2% of the world’s …
in the ability to cure chronic hepatitis C infection. However, with over 2% of the world’s …
Monoclonal antibodies directed toward the hepatitis C virus glycoprotein E2 detect antigenic differences modulated by the N-terminal hypervariable region 1 (HVR1) …
Y Alhammad, J Gu, I Boo, D Harrison… - Journal of …, 2015 - Am Soc Microbiol
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 form a heterodimer and mediate
receptor interactions and viral fusion. Both E1 and E2 are targets of the neutralizing antibody …
receptor interactions and viral fusion. Both E1 and E2 are targets of the neutralizing antibody …
The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity
K McCaffrey, H Gouklani, I Boo… - Journal of General …, 2011 - microbiologyresearch.org
The three variable regions of hepatitis C virus (HCV) glycoprotein E2 can be removed
simultaneously from the E2 ectodomain (residues 384–661) without affecting folding or CD81 …
simultaneously from the E2 ectodomain (residues 384–661) without affecting folding or CD81 …
Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding
K McCaffrey, I Boo, P Poumbourios… - Journal of …, 2007 - Am Soc Microbiol
The hepatitis C virus glycoprotein E2 receptor-binding domain is encompassed by amino
acids 384 to 661 (E2 661 ) and contains two hypervariable sequences, HVR1 and HVR2. E2 …
acids 384 to 661 (E2 661 ) and contains two hypervariable sequences, HVR1 and HVR2. E2 …
[HTML][HTML] Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core
P Poumbourios, C Langer, I Boo, T Zakir… - PLoS …, 2023 - journals.plos.org
The spike (S) glycoprotein of SARS CoV-2 is the target of neutralizing antibodies (NAbs)
that are crucial for vaccine effectiveness. The S1 subunit binds ACE2 while the S2 subunit …
that are crucial for vaccine effectiveness. The S1 subunit binds ACE2 while the S2 subunit …